| Literature DB >> 36118883 |
Weidong Ping1, Qiming Zhao1, Shuhong Ge1, Xin Wang1, Fei Li1, Xiaoxiang Huang1.
Abstract
Background: Until now, the relevance of the tanning response to sun exposure and skin diseases has incomplete and inconsistent epidemiological observations. In this case, it is valuable to find out the causality of tanning response to sun exposure and skin diseases, and take a step further toward developing effective therapies as well as prevention methods.Entities:
Keywords: Mendelian randomization; melanin pigmentation; skin diseases; sun exposure; tanning
Year: 2022 PMID: 36118883 PMCID: PMC9478173 DOI: 10.3389/fgene.2022.967696
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
FIGURE 1The flow chart of the MR study.
Summary of the outcome GWAS in the discovery study.
| Outcome trait | ID in the IEU GWAS database | Population | Number of IVs | Number of | |
|---|---|---|---|---|---|
| Cases | Controls | ||||
| Acne vulgaris | finn-b-L12_ACNE_VULGARIS | European | 125 | 1,092 | 211,139 |
| Actinic keratosis | finn-b-L12_ACTINKERA | European | 125 | 4,817 | 213,273 |
| Blepharochalasis | finn-b-H7_BLEPHAROCHALASIS | European | 125 | 4,135 | 203,231 |
| Chalazion | finn-b-H7_CHALAZION | European | 125 | 1,777 | 203,231 |
| Malignant melanoma of skin | finn-b-C3_MELANOMA_SKIN | European | 125 | 98 | 218,694 |
| Melanocytic naevi | finn-b-CD2_BENIGN_MELANOCYTIC | European | 125 | 4,035 | 214,757 |
| Prurigo nodularis | finn-b-L12_PRURIGONOD | European | 125 | 309 | 198,740 |
| Seborrhoeic dermatitis | finn-b-L12_SEBORRHOEIC | European | 125 | 1,253 | 198,740 |
| Seborrhoeic keratosis | finn-b-L12_SEBORRKERAT | European | 125 | 2,434 | 207,482 |
| Freckles | ebi-a-GCST006091 | East Asian | 35 | 7,148 | 4,034 |
MR results between tanning response to sun exposure and ten skin diseases in the discovery study.
| Outcome trait | IVW | MR Egger | Weighted median | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Beta | Se |
| FDR | Beta | se |
| Beta | se |
| |
| Actinic keratosis | 1.19 | 0.09 | 1.71E-41 | 1.71E-40 | 1.28 | 0.11 | 3.46E-22 | 1.33 | 0.09 | 2.39E-45 |
| Seborrhoeic keratosis | 0.28 | 0.07 | 5.94E-05 | 2.97E-04 | 0.29 | 0.09 | 1.06E-03 | 0.27 | 0.11 | 1.30E-02 |
| Blepharochalasis | 0.22 | 0.06 | 3.90E-04 | 1.30E-03 | 0.28 | 0.08 | 2.91E-04 | 0.26 | 0.09 | 2.84E-03 |
| Seborrhoeic dermatitis | 0.29 | 0.10 | 5.15E-03 | 1.29E-02 | 0.32 | 0.12 | 1.23E-02 | 0.52 | 0.15 | 3.40E-04 |
| Malignant melanoma of skin | 0.83 | 0.35 | 1.67E-02 | 2.95E-02 | 1.01 | 0.42 | 1.91E-02 | 0.63 | 0.51 | 2.12E-01 |
| Freckles | 1.01 | 0.42 | 1.77E-02 | 2.95E-02 | 0.93 | 0.66 | 1.69E-01 | 0.77 | 0.23 | 1.02E-03 |
| Melanocytic naevi | 0.12 | 0.07 | 6.04E-02 | 8.62E-02 | 0.09 | 0.08 | 2.55E-01 | 0.19 | 0.09 | 3.02E-02 |
| Chalazion | 0.14 | 0.08 | 9.83E-02 | 1.23E-01 | 0.14 | 0.10 | 1.63E-01 | 0.08 | 0.12 | 5.05E-01 |
| Acne vulgaris | -0.06 | 0.10 | 5.43E-01 | 6.03E-01 | -0.13 | 0.12 | 3.06E-01 | -0.07 | 0.16 | 6.49E-01 |
| Prurigo nodularis | 0.05 | 0.19 | 8.15E-01 | 8.15E-01 | 0.09 | 0.24 | 7.14E-01 | 0.14 | 0.28 | 6.16E-01 |
Abbreviations: se, standard error; IVW, inverse variance weighted; MR, mendelian randomization; FDR, false discovery rate adjusted p value.
The results of sensitivity analyses in the discovery MR study.
| Outcome | Horizontal pleiotropy | Heterogeneity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Egger intercept | se |
| IVWQ | IVW Q df | IVW | MR Egger Q | MR Egger Q df | MR Egger | |
| Actinic keratosis | −7.69E-03 | 5.35E-03 | 0.15 | 367.34 | 124 | 6.41E-26 | 361.28 | 123 | 2.82E-25 |
| Seborrhoeic keratosis | −5.50E-04 | 4.34E-03 | 0.90 | 131.74 | 124 | 3.00E-01 | 131.73 | 123 | 2.79E-01 |
| Blepharochalasis | −5.45E-03 | 3.86E-03 | 0.16 | 168.62 | 124 | 4.77E-03 | 165.93 | 123 | 5.99E-03 |
| Seborrhoeic dermatitis | −2.78E-03 | 6.32E-03 | 0.66 | 150.25 | 124 | 5.44E-02 | 150.01 | 123 | 4.93E-02 |
| Malignant melanoma of the skin | −1.56E-02 | 2.15E-02 | 0.47 | 138.46 | 124 | 1.77E-01 | 137.87 | 123 | 1.70E-01 |
| Freckles | 3.52E-03 | 2.33E-02 | 0.88 | 227.28 | 34 | 1.91E-30 | 227.12 | 33 | 7.68E-31 |
| Melanocytic naevi | 2.79E-03 | 4.03E-03 | 0.49 | 191.57 | 124 | 9.46E-05 | 190.83 | 123 | 8.60E-05 |
| Chalazion | −4.82E-04 | 5.23E-03 | 0.93 | 143.73 | 124 | 1.09E-01 | 143.72 | 123 | 9.76E-02 |
| Acne vulgaris | 5.77E-03 | 6.23E-03 | 0.36 | 113.06 | 124 | 7.50E-01 | 112.20 | 123 | 7.48E-01 |
| Prurigo nodularis | −3.68E-03 | 1.20E-02 | 0.76 | 134.06 | 124 | 2.53E-01 | 133.96 | 123 | 2.35E-01 |
Abbreviations: se, standard error; IVW, inverse variance weighted; MR, mendelian randomization; Q, Cochran’s Q test estimate; df, Cochran’s Q test degrees of freedom.
FIGURE 2Comparison of MR methods and results associated with actinic keratosis. (A) Scatter plot reflects SNP effects on the actinic keratosis against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
FIGURE 3Comparison of MR methods and results associated with seborrhoeic keratosis: (A) scatter plot reflects SNP effects on the seborrhoeic keratosis against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
FIGURE 4Comparison of MR methods and results associated with blepharochalasis: (A) scatter plot reflects SNP effects on the blepharochalasis against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
FIGURE 5Comparison of MR methods and results associated with seborrhoeic dermatitis: (A) scatter plot reflects SNP effects on seborrhoeic dermatitis against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
FIGURE 6Comparison of MR methods and results associated with malignant melanoma of the skin: (A) scatter plot reflects SNP effects on the malignant melanoma of skin against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
FIGURE 7Comparison of MR methods and results associated with freckles: (A) scatter plot reflects SNP effects on the freckles against SNP effects on the exposure; (B) forest plot represents the causal effect of exposure on the outcome using each SNP singly.
Summary of the outcome GWAS in the replication study.
| Outcome | ID in the IEU GWAS database | Population | Number of IVs | Number of | |
|---|---|---|---|---|---|
| Cases | Controls | ||||
| Actinic keratosis | ukb-d-L12_ACTINKERA | European | 122 | 1,349 | 359,845 |
| Chalazion | ukb-d-H7_CHALAZION | European | 123 | 1,418 | 359,776 |
| Malignant melanoma of skin | ukb-d-C3_MELANOMA_SKIN | European | 127 | 2,534 | 358,660 |
| Melanocytic naevi | ukb-d-D22 | European | 127 | 3,501 | 357,693 |
| Seborrhoeic keratosis | ukb-b-501 | European | 78 | 1,957 | 461,053 |
MR results between tanning response to sun exposure and five skin diseases in the replication study.
| Outcome | IVW | MR Egger | Weighted median | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Beta | se |
| Beta | se |
| Beta | se |
| |
| Malignant melanoma of skin | 8.11E-03 | 6.18E-04 | 2.13E-39 | 8.81E-03 | 7.27E-04 | 8.21E-23 | 8.81E-03 | 6.00E-04 | 8.78E-49 |
| Actinic keratosis | 3.46E-03 | 2.93E-04 | 4.64E-32 | 3.56E-03 | 3.48E-04 | 4.55E-18 | 3.52E-03 | 4.98E-04 | 1.39E-12 |
| Melanocytic naevi | 2.17E-03 | 6.87E-04 | 1.58E-03 | 1.88E-03 | 8.17E-04 | 2.28E-02 | 1.49E-03 | 8.11E-04 | 6.62E-02 |
| Seborrhoeic keratosis | 1.37E-03 | 4.38E-04 | 1.79E-03 | 1.45E-03 | 5.56E-04 | 1.09E-02 | 1.28E-03 | 6.01E-04 | 3.28E-02 |
| Chalazion | 2.01E-04 | 3.18E-04 | 5.27E-01 | -2.00E-04 | 3.72E-04 | 5.92E-01 | 2.85E-05 | 4.35E-04 | 9.48E-01 |
Abbreviations: se, standard error; IVW, inverse variance weighted; MR, mendelian randomization; FDR, false discovery rate adjusted p value.
The results of sensitivity analyses in the replication MR study.
| Outcome | Horizontal pleiotropy | Heterogeneity | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Egger intercept | se |
| IVWQ | IVWQ df | IVW | MR Egger Q | MR Egger Q df | MR Egger | |
| Malignant melanoma of skin | −7.25E-05 | 4.09E-05 | 0.08 | 300.23 | 126 | 2.98E-16 | 292.88 | 125 | 1.67E-15 |
| Actinic keratosis | −1.11E-05 | 1.95E-05 | 0.57 | 117.60 | 121 | 5.71E-01 | 117.28 | 120 | 5.53E-01 |
| Melanocytic naevi | 2.98E-05 | 4.60E-05 | 0.52 | 262.18 | 126 | 1.36E-11 | 261.30 | 125 | 1.17E-11 |
| Seborrhoeic keratosis | −5.67E-06 | 2.29E-05 | 0.80 | 91.73 | 77 | 1.21E-01 | 91.66 | 76 | 1.07E-01 |
| Chalazion | 4.18E-05 | 2.09E-05 | 0.05 | 135.98 | 122 | 1.83E-01 | 131.63 | 121 | 2.40E-01 |
Abbreviations: se, standard error; IVW, inverse variance weighted; MR, mendelian randomization; Q, Cochran’s Q test estimate; df, Cochran’s Q test degrees of freedom.